Bioelectronics Corp (BIEL)

[Ryoko]

Don't think so despite the recent dilution. The numbers were based on 1.3B shares outstanding. These are high margin devices and they only need to sell around 25M units globally to hit that mark. Given the margins and what seems to be excellent market acceptance so far, I think it's doable. But we won't really know for sure until we actually get the approvals and start seeing some actual sales numbers.